31 min
Episode 10: Next-Generation Therapeutic Antibody Discovery BioRad.io
-
- Life Sciences
Over the past three decades, since the first monoclonal antibody was approved for clinical use in the U.S., antibody techniques and technologies have advanced radically. However, the supporting informatics have evolved at a much slower pace. There are significant informatic challenges throughout the research process, from concept to regulatory submission. How can a holistic informatics strategy support gaining clearer insights into scientific operations, make smarter decisions about their campaigns, and ultimately bring therapeutics to the clinic faster?
Guest: Colby Souders, PhD, Chief Scientific Officer, Abveris
Over the past three decades, since the first monoclonal antibody was approved for clinical use in the U.S., antibody techniques and technologies have advanced radically. However, the supporting informatics have evolved at a much slower pace. There are significant informatic challenges throughout the research process, from concept to regulatory submission. How can a holistic informatics strategy support gaining clearer insights into scientific operations, make smarter decisions about their campaigns, and ultimately bring therapeutics to the clinic faster?
Guest: Colby Souders, PhD, Chief Scientific Officer, Abveris
31 min